🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a prospective comparative randomized controlled trial investigating...
Status
Completed
Location
American University of Beirut Medical Center
Start Date
2017-03-01
Trial ID
NCT03169166
Treatments Being Tested
This research study is testing whether a weekly medication called tirzepati...
Status
Recruiting
Location
Institut de Recherches Cliniques de Montréal
Start Date
2026-05-19
Trial ID
NCT07284511
This research study is designed to evaluate the safety, tolerability, and e...
Status
Terminated
Location
UCLA Stroke Network
Start Date
2004-09
Trial ID
NCT00272909
Treatments Being Tested
One of the most commonly used regional anesthetic techniques in pediatric s...
Status
Completed
Location
Multiple Locations
Start Date
2016-06-05
Trial ID
NCT03261921
Treatments Being Tested
Combination approaches will almost certainly be required to generate durabl...
Status
Completed
Location
Zuckerberg San Francisco General Hospital, University of California San Francisco
Start Date
2020-08-01
Trial ID
NCT04357821
Treatments Being Tested
Background: X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a ...
Status
Enrolling By Invitation
Location
National Institutes of Health Clinical Center
Start Date
2025-09-10
Trial ID
NCT07113743
To test the ability of GSK256073 to block niacin-induced flushing when GSK2...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-12
Trial ID
NCT00608699
Treatments Being Tested
Cirrhosis is a form of advanced liver disease that can lead to serious comp...
Status
Recruiting
Location
Cleveland Clinic Main Campus
Start Date
2025-12-17
Trial ID
NCT07058155
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This phase Ib/II trial studies the side effects and best dose of toll-like ...
Status
Completed
Location
Stanford University, School of Medicine
Start Date
2016-11-07
Trial ID
NCT02927964
Treatments Being Tested